References

Current status of research on hyperuricemia in children and adolescents

10.3969/j.issn.2097-115x.2025.12.002 · 2025 · External reference

Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: a pooled analysis of 11 population-based studies

10.1080/07853890.2022.2083670 · 2022 · External reference

The prevalence of hyperuricemia among children and adolescents in China: a meta-analysis

10.12114/j.issn.1007-9572.2024.0614 · 2025 · External reference

Sugar-sweetened beverage consumption and risk of hyperuricemia: a longitudinal analysis of the Health Workers Cohort Study participants in Mexico

10.1093/ajcn/nqaa160 · 2020 · External reference

Natural products and extracts as xantine oxidase inhibitors - a hope for gout disease

10.2174/1381612826666200728144605 · 2021 · External reference

Association of serum uric acid concentration with components of pediatric metabolic syndrome: a systematic review and meta-analysis

10.4103/jrms.jrms_733_19 · 2020 · External reference

Pediatrics hyperuricemia in clinical practice: a retrospective analysis in 1753 children and adolescents with hyperuricemia

10.1016/j.jbspin.2024.105796 · 2025 · External reference

Serum IL-1β and IL-6 concentrations in children with hyperuricemia and their clinical significance

10.3969/j.issn.1000-3606.2017.08.008 · 2017 · External reference

Common pathophysiological mechanisms connecting dyslipidemia and hyperuricemia: a narrative review

10.26574/maedica.2025.20.3.591 · 2025 · External reference

Hyperuricemia in children and adolescents: present knowledge and future directions

10.1155/2019/3480718 · 2019 · External reference

Clinical practice consensus statement 2025: management of hyperuricemia and gout in adolescents

10.1111/1756-185x.70378 · 2025 · External reference

Serum uric acid in Korean children and adolescents: reference percentiles and association with metabolic syndrome

10.6065/apem.1938156.078 · 2020 · External reference

Impact of lifestyle modifications on alterations in lipid and glycemic profiles and uric acid values in a pediatric population

10.3390/nu14051034 · 2022 · External reference

Serum uric acid concentrations among children and adolescents in China: percentile reference values and national prevalence estimates of hyperuricemia

10.1186/s12916-026-04814-y · 2026 · External reference

2013 pediatric position development conference: executive summary and reflections

10.1016/j.jocd.2014.01.007 · 2014 · External reference

Bone mass accrual in children

10.1097/med.0000000000000849 · 2024 · External reference

Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children

10.1210/jc.2009-2057 · 2010 · External reference

A contemporary view of the definition and diagnosis of osteoporosis in children and adolescents

10.1210/clinem/dgz294 · 2020 · External reference

The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position

10.1016/j.jocd.2019.07.002 · 2019 · External reference

HR-pQCT imaging in children, adolescents and young adults: systematic review and subgroup meta-analysis of normative data

10.1371/journal.pone.0225663 · 2019 · External reference

Association between linear growth and bone accrual in a diverse cohort of children and adolescents

10.1001/jamapediatrics.2017.1769 · 2017 · External reference

Association of serum uric acid status with bone mineral density in adolescents aged 12-19 years

10.3389/fmed.2020.00255 · 2020 · External reference

Correlation analysis between serum uric acid concentrations and bone mineral density in children with obesity

10.2147/dmso.s521357 · 2025 · External reference

The inverted U-shaped association between serum vitamin D and serum uric acid status in children and adolescents: a large cross-sectional and longitudinal analysis

10.3390/nu16101492 · 2024 · External reference

Trends in serum uric acid among US adolescents

10.1038/s41390-025-04203-w · 2026 · External reference

Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children

10.1530/eje-08-0618 · 2009 · External reference

Prevalence of and trends in hyperuricemia by race and ethnicity among US adolescents, 1999-2018

10.1186/s13075-024-03427-1 · 2024 · External reference

Association of low-concentration blood lead with serum uric acid in U.S. adolescents: a cross-sectional study

10.1186/s12940-019-0524-0 · 2019 · External reference

Thiazide and loop diuretics

10.1111/j.1751-7176.2011.00512.x · 2011 · External reference

Impact of childhood metabolic syndrome components on the risk of elevated uric acid in adulthood: the Bogalusa Heart Study

10.1097/maj.0b013e31815574a4 · 2008 · External reference

Elevated uric acid concentrations link to a higher cardiometabolic risk profile in adolescents

10.1007/s40618-025-02798-9 · 2026 · External reference

Aromatase inhibitors combined with growth hormone in treatment of adolescent boys with short stature

10.3785/j.issn.1008-9292.2020.04.06 · 2020 · External reference

Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk

10.1161/hypertensionaha.122.17956 · 2022 · External reference

Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome

10.1186/1750-1172-2-48 · 2007 · External reference

The molecular physiology of uric acid homeostasis

10.1146/annurev-physiol-021113-170343 · 2015 · External reference

Dual mechanisms of hyperuricemia-associated renal injury: a systematic review of crystal-dependent and crystal-independent pathways

10.1111/1756-185x.70493 · 2025 · External reference

Glycogen storage disease type I and bone: clinical and cellular characterization

10.1007/s00223-024-01302-4 · 2024 · External reference

Lowering and raising serum urate concentrations: off-label effects of commonly used medications

10.1016/j.mayocp.2022.02.027 · 2022 · External reference

Uric acid and oxidative stress

10.2174/138161205774913255 · 2005 · External reference

RAGE deficiency obstructs high uric acid-induced oxidative stress and inflammatory response

10.1016/j.intimp.2025.114316 · 2025 · External reference

Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver

10.1074/jbc.m112.399899 · 2012 · External reference

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

10.1038/ni.1831 · 2010 · External reference

Gout-associated uric acid crystals activate the NALP3 inflammasome

10.1038/nature04516 · 2006 · External reference

Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis

10.1111/eci.12677 · 2016 · External reference

The paradoxical role of uric acid in osteoporosis

10.3390/nu11092111 · 2019 · External reference

The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors

10.1155/2021/1470380 · 2021 · External reference

Uric acid: the oxidant-antioxidant paradox

10.1080/15257770802138558 · 2008 · External reference

Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment

10.3390/ijms23063188 · 2022 · External reference

Hyperuricemia and progression of chronic kidney disease: a review from physiology and pathogenesis to the role of urate-lowering therapy

10.3390/diagnostics11091674 · 2021 · External reference

The unfolded protein response: controlling cell fate decisions under ER stress and beyond

10.1038/nrm3270 · 2012 · External reference

FGF21 attenuates high uric acid‑induced endoplasmic reticulum stress, inflammation and vascular endothelial cell dysfunction by activating Sirt1

10.3892/mmr.2021.12551 · 2022 · External reference

Progress in multiaxial coupling mechanisms of osteoporosis: insights from systems medicine on immune-inflammatory interactions, hormonal regulation, and metabolic imbalance

10.3389/fendo.2025.1705040 · 2025 · External reference

High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling

10.1152/ajpendo.00518.2020 · 2021 · External reference

Reactive oxygen species in fetal growth restriction mechanisms and therapeutic directions (review)

10.3892/ijmm.2026.5792 · 2026 · External reference

N-acetyl cysteine protects osteoblastic function from oxidative stress

10.1002/jbm.a.33211 · 2011 · External reference

Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge

10.3389/fimmu.2025.1512093 · 2025 · External reference

Gout

10.1016/s0140-6736(21)00569-9 · 2021 · External reference

Asymptomatic hyperuricaemia: a silent activator of the innate immune system

10.1038/s41584-019-0334-3 · 2020 · External reference

The impact of uric acid on musculoskeletal diseases: clinical associations and underlying mechanisms

10.3389/fendo.2025.1515176 · 2025 · External reference

Elevated uric acid is associated with a low bone mineral density in pre- but not post-menopausal women with rheumatoid arthritis: a pilot study

10.1007/s00296-024-05655-9 · 2024 · External reference

Relationship between serum uric acid concentrations and osteoporosis

10.1530/ec-23-0040 · 2023 · External reference

Isobavachin alleviates hyperuricemia-induced bone loss by GPR35-NLRP3 signal

10.1016/j.phymed.2025.157368 · 2025 · External reference

Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation

10.1016/j.yexcr.2016.03.004 · 2016 · External reference

The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review

10.3389/fimmu.2023.1222129 · 2023 · External reference

Soluble uric acid activates the NLRP3 inflammasome

10.1038/srep39884 · 2017 · External reference

Neutrophil extracellular traps induce the bone erosion of gout

10.1186/s12891-022-06115-w · 2022 · External reference

Dancr-BRG1 regulates Nfatc1 transcription and Pgc1β-dependent metabolic shifts in osteoclastogenesis

10.1073/pnas.2313656121 · 2024 · External reference

Association between musculoskeletal ultrasonography and bone remodelling markers and its role in disease monitoring of gout and hyperuricaemia

2020 · External reference

The growth plate: a physiologic overview

10.1302/2058-5241.5.190088 · 2020 · External reference

Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy

10.1152/ajprenal.00637.2014 · 2015 · External reference

Developmental regulation of the growth plate

10.1038/nature01660 · 2003 · External reference

Silencing TXNIP ameliorates high uric acid-induced in85sulin resistance via the IRS2/AKT and Nrf2/HO-1 pathways in macrophages

10.1016/j.freeradbiomed.2021.11.034 · 2022 · External reference

Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis

10.1038/s41574-022-00649-8 · 2022 · External reference

The growth plate: Zonal architecture, plasticity, and endocrine control of linear growth

10.1016/j.ghir.2026.101679.89 · 2026 · External reference

The actions of IGF-1 in the growth plate and its role in postnatal bone elongation

10.1007/s11914-020-00570-x · 2020 · External reference

A single-center's uric acid profile in girls with Turner syndrome

10.3389/fendo.2024.1442166 · 2024 · External reference

Antioxidation improves in puberty in normal weight and obese boys, in positive association with exercise-stimulated growth hormone secretion

10.1038/pr.2015.85 · 2015 · External reference

The independent association between parathyroid hormone concentrations and hyperuricemia: a national population study

10.1186/ar3769 · 2012 · External reference

Vitamin D and uric acid: Is parathyroid hormone the missing link

10.1016/j.jcte.2021.100263 · 2021 · External reference

Dual-energy X-ray absorptiometry bone densitometry in pediatrics: a practical review and update

10.1007/s00247-020-04756-4 · 2021 · External reference

Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study

10.1210/jc.2011-1111 · 2011 · External reference

UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6-17 years

10.1136/adc.2006.097642 · 2007 · External reference

Which skeletal imaging modality is best for assessing bone health in children and young adults compared to DXA? A systematic review and meta-analysis

10.1016/j.bone.2021.116013 · 2021 · External reference

Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics

10.1016/j.jocd.2019.07.001 · 2019 · External reference

Insufficient bone mineralization to sustain mechanical load of weight in obese boys: a cross-sectional study

10.1210/clinem/dgad760 · 2024 · External reference

Changes in adiposity without impacting bone health in nine- to twelve-year-old children with overweight and obesity after a one-year family-centered lifestyle behavior intervention

10.1089/chi.2022.0008 · 2023 · External reference

Impact of Graves' disease and antithyroid drug therapy on bone mineral density - pathophysiological mechanisms and clinical relevance

10.20471/acc.2022.61.03.15 · 2022 · External reference

A study on lipid metabolism in a quail model of hyperuricemia

2015 · External reference

The bones of children with obesity

10.3389/fendo.2020.00200 · 2020 · External reference

Bone density in the obese child: clinical considerations and diagnostic challenges

10.1007/s00223-016-0233-4 · 2017 · External reference

Bone deficits in children and youth with type 1 diabetes: a systematic review and meta-analysis

10.1016/j.bone.2022.116509 · 2022 · External reference

Associations between abdominal fat, psoas muscle fat, and lumbar spine bone density: insights from quantitative CT imaging

10.1186/s12891-025-08545-8 · 2025 · External reference

Management of growth disorders in puberty: GH, GnRHa, and aromatase inhibitors: a clinical review

10.1210/endrev/bnac014 · 2023 · External reference

Analysis of the correlation between body composition and serum uric acid concentrations in children aged 8–11 in Taiyuan

10.11852/zgetbjzz2022-0447 · 2022 · External reference

Clinical features and rare complications in 132 patients with hepatic glycogenosis

10.1186/s13023-025-03783-4 · 2025 · External reference

Chinese familial central precocious puberty with hyperuricemia due to recurrent DLK1 mutation: case report and review of the literature

10.1002/mgg3.2087 · 2022 · External reference

Short and long-term side effects of the Classic Ketogenic Diet in pediatric epilepsy treatment: a systematic review of clinical trials

10.1016/j.seizure.2025.08.005 · 2025 · External reference

The anatomical pathology of gout: a systematic literature review

10.1186/s12891-019-2519-y · 2019 · External reference

The association between serum uric acid concentration and the risk of fractures: a systematic review and meta-analysis

10.1007/s00198-017-4059-3 · 2017 · External reference

Associations of hyperuricemia, gout, and UA-lowering therapy with the risk of fractures: a meta-analysis of observational studies

10.1016/j.jbspin.2019.03.003 · 2019 · External reference

Pathogenesis of bone disease in multiple myeloma: from bench to bedside

10.1038/s41408-017-0037-4 · 2018 · External reference

Tumour lysis syndrome: new therapeutic strategies and classification

10.1111/j.1365-2141.2004.05094.x · 2004 · External reference

The tumor lysis syndrome

10.1056/nejmra0904569 · 2011 · External reference

Association between hyperuricaemia and clinical pathological characteristics of patients with IgA nephropathy

10.47391/jpma.413 · 2021 · External reference

Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia

10.1186/s13023-020-1321-0 · 2020 · External reference

EULAR recommendations for the use of imaging in the diagnosis and management of gout

10.1136/annrheumdis-2014-206261 · 2015 · External reference

Sex-, ethnic-, and age-specific centile curves for pQCT- and HR-pQCT-derived measures of bone structure and strength in adolescents and young adults

10.1002/jbmr.3399 · 2018 · External reference

Nutrition and osteoporosis prevention

10.1007/s11914-024-00892-0 · 2024 · External reference

High uric acid concentrations in overweight and obese children and their relationship with cardiometabolic risk factors: what is missing in this puzzle

10.1515/jpem-2021-0211 · 2021 · External reference

Obesity-induced insulin resistance is mediated by high uric acid in obese children and adolescents

10.3389/fendo.2021.773820 · 2021 · External reference

Position statement: Exercise guidelines to increase peak bone mass in adolescents

10.11005/jbm.2019.26.4.225 · 2019 · External reference

Resistance training for children and adolescents

10.1542/peds.2020-1011 · 2020 · External reference

Construction and validation of a risk prediction model for hyperuricemia in children and adolescents

2024 · External reference

Uric acid mediated the relationship between obesity and hypertension in children and adolescents: A population-based cohort study

10.1016/j.numecd.2023.10.007 · 2024 · External reference

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

10.1124/pr.58.1.6 · 2006 · External reference

Trends in adverse effects of medical treatment in paediatric populations in the United States: A global burden of disease study, 2000-2019

10.1111/ppe.13116 · 2024 · External reference

Hyperuricemia and its related diseases: mechanisms and advances in therapy

10.1038/s41392-024-01916-y · 2024 · External reference